LATS1 and hepatocellular carcinoma: PRMT1 facilitates the asymmetric di‐methylation of YAP at arginine 124, thereby diminishing the interaction between YAP and LATS1, inhibiting subsequent phosphorylation of YAP, and promoting both YAP activity and cell proliferation in hepatocellular carcinoma.